• <rp id="vpc4d"></rp>

        1. <s id="vpc4d"><object id="vpc4d"><blockquote id="vpc4d"></blockquote></object></s>

          Products & Pipeline

          全图-管线图英文20190830.jpg

          * In-house programs

          Note: The Group is also developing the tablet formulation of Ritonavir and has completed bioequivalence (BE) studies of the tablets on healthy volunteers. ANDA of Ritonavir was accepted by NMPA on August 22, 2019. Ritonavir is used as a pharmacokinetic booster of Ganovo? (Danoprevir).


          赌场直营公司_网上赌场项目_亚州体育赌场-歌礼生物科技(杭州)有限公司